In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection

Current HIV Research

Volumn 7, Issue 6, 2009, Pages 650-655

  D'Agostino, Claudia ^a   Lichtner, Miriam ^a   Mastroianni, Claudio M ^a   Ceccarelli, Giancarlo ^a   Iannetta, Marco ^a   Antonucci, Simone ^a   Vullo, Vincenzo ^a   Massetti, Anna P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

defensins; CD8; HIV; Innate immunity; Neutrophils

Indexed keywords

ALPHA DEFENSIN;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MALE; NEUTROPHIL;

ADULT; ALPHA-DEFENSINS; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 73949131142     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209789973600     Document Type: Article

References (33)

1. Levy J. The importance of innate immune system in controlling HIV infection an disease. Trends Immunol 2001; 22: 312-6.
2. Levy JA, Scott I, Mackewicz C. Protection from HIV/AIDS: the importance of innate immunity. Clin Immunol 2003; 108: 167-74.
3. Pereira LE, Ansari AA. A case for innate immune effector mechanisms as contributors to disease resistance in SIV-infected sooty mangabeys. Curr HIV Res 2009; 7: 12-22.
4. Wijewardana V, Brown KN, Barratt-Boyes SM. Studies of plasmacytoid dendritic cell dynamics in simian immunodeficiency virus infection of nonhuman primates provide insights into HIV pathogenesis. Curr HIV Res 2009; 7: 23-9.
5. Lichtner M, Rossi R, Rizza MC, et al. Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. Curr HIV Res 2008; 6: 19-27.
6. Alter G, Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med 2009; 265: 29-42.
7. Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986; 234: 1563- 6.
8. Barker E. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor. J Infect Dis 1999; 179(Suppl 3): S485-8.
9. Jan MS, Huang YH, Shieh B, et al. CC chemokines induce neutrophils to chemotaxis, degranulation, and alpha-defensin release. J Acquir Immune Defic Syndr 2006; 41: 6-16.
10. Levy JA, Mackewicz C, Barker E. Controlling HIV pathogenesis: the role of non cytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996; 17: 217-24.
11. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-5.
12. Mastroianni CM, d'Ettorre G, Forcina G, Vullo V. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy? Trends Immunol 2004; 25: 121-5.
13. Ji X, Gewurz H, Spear GT. Mannose binding lectin (MBL) and HIV. Mol Immunol 2005; 42: 145-52.
14. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-20.
15. Alfano M, Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol Immunol 2005; 42: 161-82.
16. Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol 1990; 44: 1-8.
17. Chang TL, Vargas J Jr, DelPortillo A, Klotman ME. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest 2005; 115: 765-73.
18. Wildeman Zapata W, Benigno Rodriguez B, Jan Weber J, et al. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res 2008; 6: 531-8.
19. Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002; 298: 995-1000.
20. Zhang L, Lopez P, He T, Yu W, Ho DD. Retraction of an interpretation. Science 2004; 303: 467.
21. Mackewicz CE, Yuan J, Tran P, et al. alpha-defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 2003; 17: F23-32.
22. Chang TL, Francois F, Mosoian A, Klotman ME. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol 2003; 77: 6777-84.
23. Flamand L, Borgeat P, Lalonde R, Gosselin J. Release of anti-HIV mediators after administration of leukotriene B4 to humans. J Infect Dis 2004; 189: 2001-9.
24. Folkvord JM, McCarter MD, Ryder J, Meditz AL, Forster JE, Connick E. α-defensins 1, 2, and 3 are expressed by granulocytes in lymphoid tissues of HIV-1-seropositive and -seronegative individuals. J Acquir Immune Defic Syndr 2006; 42: 529-36.
25. Trabattoni D, Caputo SL, Maffeis G, et al. Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr 2004; 35: 455-63.
26. Zaharatos GJ, He T, Lopez P, Yu W, Yu J, Zhang L. alpha-defensins released into stimulated CD8+ T-cell supernatants are likely derived from residual granulocytes within the irradiated allogeneic peripheral blood mononuclear cells used as feeders. J Acquir Immune Defic Syndr 2004; 36: 993-1005.
27. Hunt PW. Role of immune activation in HIV pathogenesis. Curr HIV/AIDS Rep 2007; 4: 42-47.
28. Brenchley JM, Price DA, Schacker TW. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71.
29. Deeks SJ, Walker BD. The immune response to AIDS virus infection: good, bad, or both? J Clin Invest 2004; 113: 808-10.
30. Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Pahwa S, Liu H. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol 2008; 126: 315-21.
31. Mastroianni CM, Lichtner M, Mengoni F, et al. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1infected patients. AIDS 1999; 13: 883-90.
32. Mastroianni CM, Mengoni F, Lichtner M, et al. Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis. J Infect Dis 2000; 182: 1536-9.
33. Mastroianni CM, d'Ettorre G, Forcina G, et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 2000; 96: 1979-84.